glp-1 with hypothyroidism and can you take glp 1

Expert Picks: Resources to Support Your Ozempic Questionnaire Process Continue your research Need guidance on telehealth compliance frameworks

Safety and tolerability of exenatide once weekly in patients with type 2 diabetes: An integrated analysis of 4,328 patients

GLP-1 receptor agonist therapy requires ongoing assessment and potential dose adjustments based on treatment response, tolerability, and evolving clinical needs

Gastrointestinal side effects are the most commonly reported and include: Nausea (affecting 1040% of patients, depending on the specific GLP-1 agonist) Vomiting and diarrhoea (less common than nausea but can contribute to dehydration) Constipation (due to slowed gastric emptying) Abdominal discomfort or bloating These effects are typically most pronounced during treatment initiation and following dose increases